IRIS
GROSSI, Laurino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.979
EU - Europa 4.504
AS - Asia 2.847
SA - Sud America 139
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 11
OC - Oceania 1
Totale 12.502
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.955
CN - Cina 976
SG - Singapore 872
UA - Ucraina 816
IT - Italia 797
IE - Irlanda 719
TR - Turchia 562
SE - Svezia 554
GB - Regno Unito 480
FR - Francia 410
IN - India 345
DE - Germania 258
FI - Finlandia 164
RU - Federazione Russa 128
BR - Brasile 118
AT - Austria 57
VN - Vietnam 37
PL - Polonia 35
EU - Europa 20
NL - Olanda 19
BE - Belgio 18
RO - Romania 15
HK - Hong Kong 13
MX - Messico 13
CA - Canada 10
IL - Israele 7
AR - Argentina 6
GR - Grecia 6
IQ - Iraq 5
TW - Taiwan 5
AL - Albania 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
ES - Italia 4
KR - Corea 4
CH - Svizzera 3
CL - Cile 3
EE - Estonia 3
IR - Iran 3
JP - Giappone 3
KE - Kenya 3
LT - Lituania 3
MA - Marocco 3
NO - Norvegia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
ID - Indonesia 2
LU - Lussemburgo 2
PE - Perù 2
PK - Pakistan 2
ZA - Sudafrica 2
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.502
Salva come PNG Salva come JPEG
Città #
Jacksonville 943
Chandler 779
Dublin 711
Singapore 500
Dearborn 468
Southend 378
Princeton 354
Nanjing 284
Izmir 272
Wilmington 254
Beijing 172
Cambridge 157
Ashburn 123
Woodbridge 119
Ann Arbor 115
Nanchang 93
Santa Clara 92
The Dalles 92
Boardman 66
Houston 61
Hebei 53
New York 51
Vienna 50
Shenyang 48
Altamura 47
Kunming 45
Rome 44
Tianjin 43
Jiaxing 40
Los Angeles 38
Kraków 35
Pescara 35
Chieti 29
Hefei 29
Hangzhou 27
Bologna 25
Norwalk 25
Dong Ket 22
Düsseldorf 20
Jinan 20
Changsha 19
Ancona 18
Milan 18
Orange 18
Brussels 17
Helsinki 16
Bellante 15
Washington 15
Grevenbroich 14
Guangzhou 14
Lanzhou 14
Vinh 14
Hong Kong 12
Fuzhou 11
Falls Church 10
Cepagatti 9
Changchun 9
Guadalajara 9
Ningbo 8
Seattle 8
Turin 8
Amsterdam 7
Edinburgh 7
L'aquila 7
Mumbai 7
São Paulo 7
Varallo 7
Brasília 6
London 6
Munich 6
Nuremberg 6
Auburn Hills 5
Belo Horizonte 5
Frankfurt am Main 5
Ripa Teatina 5
San Vito al Tagliamento 5
Villamagna 5
Ascoli Piceno 4
Isernia 4
Redwood City 4
Senigallia 4
Siena 4
Simi Valley 4
Sulmona 4
Walnut 4
Xian 4
Zhengzhou 4
Avezzano 3
Baghdad 3
Baotou 3
Brno 3
Castelfranco di Sotto 3
Cedar Knolls 3
Duncan 3
Guayaquil 3
Marseille 3
Moscow 3
Mountain View 3
Nairobi 3
Palermo 3
Totale 7.210
Salva come PNG Salva come JPEG
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 364
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 157
Ottimizzazione di vedolizumab in RCU con perdita di risposta a infliximab 123
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 123
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 122
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 118
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 117
24-hour pancolonic motility using a portable electronic probe in healthy subjects 116
Blood cardioplegia: could it protect the ischemic-reperfused human myocardium through antioxidant-type mechanisms? 115
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 114
Trasmissione di Helicobacter pylori in un modello murino 109
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 105
Alterazioni non litiasiche del contenuto colecistico 104
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 104
ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT 104
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 103
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 101
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 101
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 100
USO DI GOLIMUMAB COME SECONDA LINEA BIOLOGICA IN UN PAZIENTE CON RETTOCOLITE ULCEROSA 98
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 97
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 97
REAL-LIFE STUDY (GORE-UC) EVALUATING THE EFFECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD). 95
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 95
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 94
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 93
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 93
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 92
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 91
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 91
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 88
Transmission of Helicobacter pylori in an animal model. 88
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 87
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 87
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 85
Detection of Helicobacter pylori in esophagus and saliva in humans 85
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 85
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 84
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 84
THERAPY-RELATED ADVERSE EVENTS IN CROHN’S DISEASE (CD) – A COMPARISON BETWEEN THIOPURINES, INFLIXIMAB AND COMBINED THERAPY 84
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 84
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 83
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 83
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 82
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 82
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 82
A “REAL LIVE” EXPERIENCE OF INFLIXIMAB USE FOR CROHN’S DISEASE IN SOUTHERN ITALY 82
EFFICACY AND SAFETY OF LONG-TERM INFLIXIMAB USE FOR CROHN’S DISEASE IN SOUTHERN ITALY 82
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 82
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 82
Esophageal and gastric motility in patients with gastroesophageal reflux disease 81
GRAVIDANZA IN UNA PAZIENTE AFFETTA DA RETTOCOLITE ULCEROSA IN TERAPIA CON INFLIXIMAB: CASO CLINICO 81
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 81
THERAPY- RELATED ADVERS EVENTS IN CROHN’S DISEASE (CD) – A COMPARISON BETWEEN THIOPURINES, INFLIXIMAB AND COMBINED THERAPY 81
RISPOSTA CLINICA E GUARIGIONE DELLA MUCOSA DOPO 4 ANNI DI TERAPIA CON INFLIXIMAB IN UN PAZIENTE CON MALATTIA DI CROHN ILEALE STEROIDO-RESISTENTE 80
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 80
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 80
REAL-LIFE STUDY (GORE-UC) EVALUATING THE EFFECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMAMTORY BOWEL DISEASE (IG-IBD). 80
Peppermint oil (Mintoil®) in the treatment or irritable bowel syndrome: a prospective double blind placebo controlled randomized trial. 79
Increase of swallows before the onset of phase III of migrating motor complex in normal human subjects 79
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 79
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 78
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 78
LA MALDIGESTIONE 78
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 78
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 77
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 77
EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN’S DISEASE 77
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 76
null 76
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 75
CLINICAL AND ECONOMIC IMPACT OF INFLIXIMAB ONE-HOUR INFUSION PROTOCOL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A MULTICENTER STUDY 75
FPSE-HPLC-PDA METHOD FOR THE DETERMINATION OF INFLAMMATORY BOWEL DISEASE TREATMENT DRUGS IN WHOLE BLOOD, PLASMA AND URINE 75
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 74
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 74
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 74
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 74
Erythromycin accellerates gastric and gallbladder emptying through a cholinergic mediated mechanism in humans 74
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 73
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 73
EFFECT OF HYOSCINE N-BUTYLBROMIDE ON GASTROESOPHAGEAL REFLUX IN NORMAL SUBJECTS AND PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 73
CLINICAL AND ECONOMIC EFFECT OF SHORT INFLIXIMAB INFUSION PROTOCOL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A MULTICENTRE STUDY 73
THE VALUE OF CONTRAST ENHANCED ENDOSCOPIC ULTRASOUND IN THE FINE NEEDLE ASPIRATION 73
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 72
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 72
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 71
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 71
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 71
Mouth to caecum transit time (MCTT) is accellerated after oral food antigen in patients with irritable bowel syndrome 71
EVALUATION OF INTRA PARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSIS BY FIBROSCAN IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPARISON WITH NORMAL CONTROLS 71
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 70
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 70
LA MALATTIA DA REFLUSSO GASTROESOFAGEO 70
Prolonged anal sphincter manometry in normal human subjects 69
EVALUATION OF FIBROSIS AND INTRAPARENCHIMAL BLOOD FLOW INCHIRROTIC PATIENTS, CHRONIC ACTIVE HEPATITIS AND NORMAL CONTROLS THROUGH FIBROSCAN AND ULTRASOUND ENHANCED CONTRAST MEDIA. 69
Effect of nitric oxide on propagated clusters of spontaneous motor waves in an ex vivo rabbit intestinal preparation 69
Registrazione delle 24 ore della motilità del piloro in soggetti normali 68
GASTRIC AND GALLBLADDER EMPTYING AFTER STANDARD SOLID MEAL IN NORMAL CONTROLS, PATIENTS WITH “MOTILITY-LIKE” DYSPEPSIA AND EFFECT OF DOMPERIDONE. 68
EFFICACY AND SAFETY OF GOLIMUMAB IN ULCERATIVE COLITIS. PRELIMINARY DATA FROM A MULTICENTER ITALIAN STUDY 68
Evidence for an oral-faecal transmission of Helicobacter pylori infection in an experimental murine model 67
Totale 8.840
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.619
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020210 0 0 0 0 0 0 0 0 0 0 203 7
2020/2021983 163 3 182 17 82 227 18 23 30 135 21 82
2021/2022789 35 15 4 200 46 16 24 66 54 9 88 232
2022/20232.154 188 207 108 264 194 488 145 158 253 41 59 49
2023/20241.002 79 51 62 36 34 292 236 37 14 44 19 98
2024/20251.800 182 423 292 47 54 66 99 173 310 121 33 0
Totale 12.793